Exo Imaging Exit Candidate
π¦ Potential exit path:
SPAC, IPO, M&A

Funding π°
Total $307.6M
Select investors RA Capital Management, Action Potential Venture Capital, Applied Ventures, BlackRock, Bold Capital Partners, Creative Ventures, Intel Capital, OSF Ventures, Pura Vida Investments
Key people π§βπ€βπ§
- Sandeep Akkaraju - Co-Founder & CEO
- Janusz Bryzek, Ph.D. - Co-Founder and Board Chairman
- Yusuf Haque, Ph.D. - CTO
- Lori Munoz - CFO
- Joe Adam - EVP, Operations
Highlights β
- Exo's team has experience in developing and delivering global innovation in medical technology - Eric King & Christian Buerger from Intel Capital π
- Exo's piezoelectric transducer is a differentiator that allows the company to have the ability to deliver low-cost, high-quality imaging to new and expanding audiences - Eric King & Christian Buerger from Intel Capital π
- The ultrasound market is undergoing a fundamental transformation toward more distributed use and Exo is positioned to become a market leader as a result - RA Capital Management principal Zach Scheiner, Ph.D π
- The company has support from major healthcare & pharma firms such as GSK (through Action Potential Venture Capital) and OSF HealthCare (through OSF Ventures) π
- And also from strategic supply chain-focused investors such as Intel Capital, TDK Ventures, Compal and Applied Ventures π
- Similar companies: Butterfly Network
Last update: September 6, 2021
Disclaimer: We can not guarantee that the information on this page is 100% correct. more